Evaluation of Naringin and Rutin to Reverse Doxorubicin Induced Cognitive Deficits in Rat Model of Mammary Carcinoma

dc.contributor.guide	Nandakumar, K
dc.coverage.spatial	Pharmaceutical Sciences
dc.creator.researcher	Ramalingayya, Grandhi V
dc.date.accessioned	2017-01-17T09:13:47Z
dc.date.available	2017-01-17T09:13:47Z
dc.date.awarded	n.d
dc.date.completed	2015
dc.date.registered	n.d
dc.description.abstract	Abstract available newline newline newline
dc.description.note	Summary given
dc.format.accompanyingmaterial	None
dc.format.dimensions	-
dc.format.extent	n.d.
dc.identifier.uri	http://hdl.handle.net/10603/125620
dc.language	English
dc.publisher.institution	Manipal College of Pharmaceutical Sciences
dc.publisher.place	Manipal
dc.publisher.university	Manipal University
dc.relation	-
dc.rights	university
dc.source.inflibnet	INFLIBNET
dc.subject.keyword	Carcinoma
dc.subject.keyword	Deficits
dc.subject.keyword	Doxorubicin
dc.subject.keyword	Evaluation
dc.title	Evaluation of Naringin and Rutin to Reverse Doxorubicin Induced Cognitive Deficits in Rat Model of Mammary Carcinoma
dc.title.alternative	-
dc.type.degree	Ph.D.